Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)

PHASE3CompletedINTERVENTIONAL
Enrollment

437

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

February 16, 2022

Study Completion Date

February 16, 2022

Conditions
Infertility, Female
Interventions
DRUG

FE 999049 + GnRH agonist (GONAPEPTYL)

Pre-filled injection pen

DRUG

FE 999049 + GnRH antagonist (CETROTIDE)

Powder and solvent for solution for injection

Trial Locations (16)

Unknown

Das Kinderwunsch Institut Schenk GmbH, Dobl

Kepler University Hospital Linz, Linz

Kinderwunschzentrum Goldenes Kreuz Privatklinik, Vienna

Rigshospitalet, Copenhagen

Hillel Yafe Medical Center, Hadera

Shaare Zedek Medical Center, Jerusalem

Beilinson Hospital Rabin Medical Center, Petah Tikva

Sourasky Medical Center, Tel Aviv

Dipartimento della Donna, del bambino e delle malattie urologiche, Bologna

European Hospital, Roma

St. Elisabeth Ziekenhuis, Tilburg

Isala Fertility Center, Zwolle

Oslo University Hospital, Oslo

Sykehuset Telemark HF, Porsgrunn

Medicus AS, Trondheim

Gyn-A.R.T. AG, Zurich

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY